Clinical Trial Update: Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fulvestrant plus anastrozole versus anastrozole alone in breast cancer reported terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Anastrozole (Anastrozole)
• Faslodex (fulvestrant)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2019-04-05